Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
PTC Therapeutics secures $1 billion deal with Novartis for Huntington's disease treatment.
PTC Therapeutics has signed a major deal with Novartis for its Huntington's disease treatment PTC518, securing a $1 billion upfront payment and up to $1.9 billion in future milestones.
Novartis will take over global development and commercialization post a key study, while sharing U.S. profits with PTC.
PTC’s stock surged over 15% on the news, reflecting the significant financial and potential therapeutic impact of the collaboration.
16 Articles
PTC Therapeutics asegura un acuerdo de $1 mil millones con Novartis para el tratamiento de la enfermedad de Huntington.